Editorial: Advances in spinal muscular atrophy.
作者信息
Sun Jianli
机构信息
Delaware Center for Neuroscience Research, Department of Biological Sciences, Delaware State University, Dover, DE, United States.
出版信息
Front Cell Neurosci. 2023 Mar 17;17:1178422. doi: 10.3389/fncel.2023.1178422. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Advances in spinal muscular atrophy.社论：脊髓性肌萎缩症的进展
Front Cell Neurosci. 2023 Mar 17;17:1178422. doi: 10.3389/fncel.2023.1178422. eCollection 2023.
2
The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.脊髓性肌萎缩症小鼠模型中有症状性生存运动神经元恢复的神经肌肉影响
Neurobiol Dis. 2016 Mar;87:116-23. doi: 10.1016/j.nbd.2015.12.014. Epub 2015 Dec 28.
3
Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn mouse model of spinal muscular atrophy.脊髓运动神经元的丧失是通过脊髓性肌萎缩症 Smn 小鼠模型中的 p53 和 p21 非依赖性机制发生的。
Exp Neurol. 2021 Mar;337:113587. doi: 10.1016/j.expneurol.2020.113587. Epub 2020 Dec 28.
4
Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.激活脊髓性肌萎缩症中的 ATF6 通过 IRE1α-XBP1 通路促进 SMN 表达和运动神经元存活。
Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12816. doi: 10.1111/nan.12816. Epub 2022 Mar 30.
5
The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy.口服剪接修饰剂 RG7800 增加运动神经元 2 mRNA 的全长存活和运动神经元蛋白的存活：在健康成年人和脊髓性肌萎缩症患者中进行的试验结果。
Neuromuscul Disord. 2019 Jan;29(1):21-29. doi: 10.1016/j.nmd.2018.10.001. Epub 2018 Oct 30.
6
Recapitulation of spinal motor neuron-specific disease phenotypes in a human cell model of spinal muscular atrophy.脊髓性肌萎缩症人类细胞模型中脊髓运动神经元特异性疾病表型的总结。
Cell Res. 2013 Mar;23(3):378-93. doi: 10.1038/cr.2012.166. Epub 2012 Dec 4.
7
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.CHP1 减少通过恢复钙调神经磷酸酶活性和内吞作用改善脊髓性肌萎缩症病理。
Brain. 2018 Aug 1;141(8):2343-2361. doi: 10.1093/brain/awy167.
8
Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.肌肉特异性 SMN 减少揭示了脊髓性肌萎缩症模型中运动神经元独立性疾病。
J Clin Invest. 2020 Mar 2;130(3):1271-1287. doi: 10.1172/JCI131989.
9
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.肌抑素抑制联合反义寡核苷酸疗法改善脊髓性肌萎缩症的预后。
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):768-782. doi: 10.1002/jcsm.12542. Epub 2020 Feb 7.
10
Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.脊髓性肌肉萎缩症和运动神经元存活蛋白（SMN）的抗细胞凋亡作用。
Mol Neurobiol. 2013 Apr;47(2):821-32. doi: 10.1007/s12035-013-8399-5. Epub 2013 Jan 13.
本文引用的文献
1
Advances and limitations for the treatment of spinal muscular atrophy.脊髓性肌萎缩症治疗的进展与局限。
BMC Pediatr. 2022 Nov 3;22(1):632. doi: 10.1186/s12887-022-03671-x.
2
264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th - 21st 2021.第264届ENMC国际研讨会：脊髓性肌萎缩症的多系统受累，荷兰霍夫多普，2021年11月19日至21日。
Neuromuscul Disord. 2022 Aug;32(8):697-705. doi: 10.1016/j.nmd.2022.06.005. Epub 2022 Jun 17.
3
Curing SMA: Are we there yet?治愈脊髓性肌萎缩症：我们做到了吗？
Gene Ther. 2023 Feb;30(1-2):8-17. doi: 10.1038/s41434-022-00349-y. Epub 2022 May 26.
4
Onasemnogene abeparvovec for the treatment of spinal muscular atrophy.依洛硫酸酯酶 n 注射液治疗脊髓性肌萎缩症。
Expert Opin Biol Ther. 2022 Sep;22(9):1075-1090. doi: 10.1080/14712598.2022.2066471. Epub 2022 May 2.
5
LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy.LCM-seq 揭示了耐药神经元独特的转录适应机制，并确定了脊髓性肌萎缩症中的保护途径。
Genome Res. 2020 Aug;30(8):1083-1096. doi: 10.1101/gr.265017.120. Epub 2020 Aug 20.
6
Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease.颠覆脊髓性肌萎缩症仅仅是运动神经元疾病这一范式。
Pediatr Neurol. 2020 Aug;109:12-19. doi: 10.1016/j.pediatrneurol.2020.01.003. Epub 2020 Jan 22.
7
Systemic nature of spinal muscular atrophy revealed by studying insurance claims.通过研究保险索赔揭示了脊髓性肌萎缩症的系统性本质。
PLoS One. 2019 Mar 14;14(3):e0213680. doi: 10.1371/journal.pone.0213680. eCollection 2019.
8
Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.核因子-κB 通路对小鼠脊髓运动神经元中存活运动神经元蛋白的调节作用。
Mol Neurobiol. 2018 Jun;55(6):5019-5030. doi: 10.1007/s12035-017-0710-4. Epub 2017 Aug 14.
9
A multi-source approach to determine SMA incidence and research ready population.一种用于确定脊髓性肌萎缩症发病率和适合研究人群的多源方法。
J Neurol. 2017 Jul;264(7):1465-1473. doi: 10.1007/s00415-017-8549-1. Epub 2017 Jun 20.
10
Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.脊髓性肌萎缩症 Smn（2b/-）小鼠模型在症状前阶段差异易损运动神经元的转录谱分析。
Acta Neuropathol Commun. 2015 Sep 15;3:55. doi: 10.1186/s40478-015-0231-1.
Zotero 插件